Sensitivity and specificity of neuropathy diabetes score, neuropathy symptoms score, diabetic neuropathy score and esthesiometry compared with the gold standards Michigan neuropathy screening instrument (MNSI) and Beck depression inventory (BDI)
© Dias et al. 2015
Published: 11 November 2015
In a previous study, we observed that the Results of an organized questionnaire to assess the presence of diabetic neuropathy (Diabetic Neuropathy Symptoms-DNS) were associated with the presence of scores of depressive symptoms (BDI ≥10).
To evaluate how different scores for the presence of symptoms/signs of neuropathy (Neuropathy Diabetes Score-NDS; Neuropathy Symptoms Score-NSS; DNS and esthesiometry) had sensitivity and specificity, compared to the gold standard score of Michigan (MNSI) (≥2,5) and the gold standard score of Beck depressive symptoms (BDI).
Materials and methods
207 patients with Diabetes type 2 were evaluated with MNSI, BDI, NDS, esthesiometry, NSS and DNS.
We suggest not to use only questionnaires to define the presence of neuropathy in diabetic patients-in daily practice, physical examination (MNSI or NDS) must be used.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.